7th Annual Academic Summit

Breakthroughs in Brain Health, CVD, and Autoimmunity

(formerly Hormones and Beyond)

Next Event:

September 16-18, 2022

$795.00 – $1095.00

Virtual or In Person | Albuquerque, NM

REGISTER NOW

Get Program Info

Details

Description

This year promises all new content with a specialized focus on breakthroughs in brain health. We’ll address the intriguing topic of inflammation and hormones as they relate to dementia. Worldwide, around 50 million people suffer from dementia, and nearly 10 million new cases are diagnosed every year. Two expert presenters will address the subject.

Hormone expert, Neil Rouzier, MD, will address several exciting articles about the emerging research related to AD treatment such as:

  • How exercise and estrogen relate to dementia.
  • The multifactorial root causes of dementia.
  • How insulin resistance relates to dementia.
  • How the “wrong” tau protein contributes to dementia.

Ken Sharlin, MD, is a traditional Neurologist trained in hormones and functional medicine. His functional medicine background allows him to apply a multi-dimensional approach to the treatment of dementia, rather than the traditional approach that only treats dementia’s symptoms. Ken will address several key topics related to dementia such as:

  • The seven biological systems that affect brain health and dementia that you have
    probably never heard of.
  • The role of the glymphatic system, the brain’s waste clearance system, and dementia.
  • The importance of an intact blood-brain barrier and a “leaky brain.”

Bringing Dr. Rouzier’s hormone expertise as it relates to dementia paired with Dr. Sharlin’s treatment toolkit will ensure that all attendees are well positioned to prevent and improve patient outcomes in a variety of areas, including dementia.

Third, we’ll discuss the latest research to support the therapeutic use of Human Growth Hormone (HGH).

The regulatory environment for providers continues to be a high priority for this community, and what better arena to bring up relevant issues and concerns? In this part of the course, we’ll do case studies with Keith Nichols, MD, on patient documentation and medical board auditing. We’ll follow this with a lecture from legal expert, Rick Collins, on navigating the current regulatory environment.

Last but not least, Dr. Pang will be giving a prostate cancer update, and special guest faculty, Dipnarine Maharaj, MD, will explore the importance of a healthy immune system in our fight against illness. He does this by taking a personalized approach, using three decades of experience with advanced stem cell treatment and his in-depth understanding of blood and immune disorders to maximize the health and effectiveness of the body’s natural defense system.

Access: This workshop is offered in-person and/or virtually. You can choose if you would like to be shipped printed educational materials. We will also post a recording for each day that same evening. The recording will be available until Thursday of the week after the event to re-watch or catch up on anything you may have missed, but it will not be available after this time.

Accreditation: 19.25 AMA PRA Category 1 Credits | 19.25 Nursing Contact Hours | 19.25 Hours Pharmacy Credit 

This activity has been planned and implemented by The Foundation for Care Management (FCM) and Worldlink Medical. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive (19.25 hours) Interprofessional Continuing Education (IPCE) credit for learning and change. 

Topics

Agenda

Friday

Registration
7:00 – 8:00 a.m.

 

Opening Remarks
Neal Rouzier, MD

8:00 – 9:00 a.m.
Guest Speaker: Neal Rouzier, MD

Alzheimer’s Disease: Pathophysiology, Risks, Causes, and Prediction
● Ways to improve microglia dysfunction induced by inflammation.
● Warning signs of AD in its earliest stages before the full-blown disease manifests (don’t
wait for the house to burn down before trying to put out the fire!)
● How to diagnose pre-AD.
● Discussion of the two different types of AD and its four different stages.

Alzheimer’s Disease (AD) and its treatment is a controversial subject among medical
professionals. During this portion of the summit, we will apply critical thinking and
research to address the following questions:

● Is it really the beta-amyloid protein that is the cause of dementia or is it an adaptive
innocent bystander of a different disease process? If it is the former, then why do some
patients with significant build-up of beta-amyloid plaque not get AD?
● Could tauopathy be the real pathology behind AD that incrementally increases the
deposition of beta-amyloid protein? If so, is neuro-inflammation the source of the
tauopathy?.
● Is it the insulin resistance (IR) induced microglial dysfunction that prevents the clearing
of the tauopathy that then prevents clearing of the neuro-fibrillary tangles and beta-
amyloid protein?
● If all of these factors contribute to the development and progression of dementia, then
what is the true cause of AD?
● What to do with APOE ε4.
● What is the work-up for AD? How much money should be spent testing for AD?
● Review the most common cause of AD
● The viewpoint of Alzheimer’s Disease as “type 3 diabetes” and a direct result of both
insulin resistance and hyperinsulinemia , including a literature review on how to resolve
both.
● A quick review of why there is a continual increase in risk of CVD, DM, NAFLD,
NAFPD, AD, vascular dementia, and cancer. Can’t we see the elephant in the room?

 

9:00 – 9:15 a.m.
Question and Answer

 

9:15 – 10:15 a.m.
Guest Speaker: Neal Rouzier, MD

How Not to Treat Alzheimer’s Disease (Despite FDA-Approval of Aducanumab)
● Side effects, problems, complications, and restrictions of aducanumab. For example, no
hormone causes brain swelling or intracranial hemorrhage as does aducanumab.
● How to treat Alzheimer’s Disease based on EBM.
● Connecting the dots, as the disease is multifactorial (let’s see the elephant in the room!)
● Why hormones hold the key for treating and reversing type 2 diabetes and type 3 diabetes
which are the greatest risk factors for AD.
● How to increase the risk of AD. Rather, what drugs do we prescribe to patients that
increase the risk of AD?

 

10:15 – 10:30 a.m.
Question and Answer

 

10:30 – 10:45 a.m. BREAK

 

10:45 – 11:45 a.m.
Guest Speaker – Neal Rouzier, MD
Estrogen Deficiency/Deprivation & Alzheimer’s Disease/Vascular Dementia (VD)
Review a plethora of data demonstrating how E2 reverses the multifactorial pathology of
AD and VD.
● Review SPECT scan results of BHRT in contrast to SHRT.
● Review the best, most recent study on HRT and AD, including which hormones work the
best and which ones don’t.
● Review what types of HRT work the best and which ones don’t.
● “The window of opportunity” for HRT fallacy. Is there really a window of opportunity
for HRT?
● The best type of doctor/specialist to prevent and treat AD in women? Who understands it
the best?

 

11:45 – 12:00 Noon
Question and Answer

 

12:00 – 1:15 p.m. LUNCH

 

1:15 – 2:15 p.m.
Guest Speaker – Ken Sharlin MD
21st Century Neuroscience: The Brain and Brain Health
The evidenced-based scientific foundation for the clinical application of the principles you will
learn in Part 2 of my lectures.
Current paradigm of disease-centered medicine, advantages, and disadvantages.
● Review patient-centered models as an alternative therapeutic strategy in chronic disease
management as well as neurological health and disease.
● Discuss the normal process of the aging brain which creates inherent limitations with a
lifestyle-only approach.
● Additional considerations around hormone changes with age and how this affects the
brain and cellular senescence.

 

2:15 – 3:00 p.m.
Guest Speaker – Herman Pang, MD
Prostate Cancer Case Study Update

 

3:00 – 3:15 p.m. – BREAK

 

3:15 – 5:15 p.m.
Guest Speaker – Dipnarine Maharaj, MD
Solutions for Aging of the Immune System and the Associated Diseases

Followed by Q & A

 

5:15 – 5:30 pm
Question and Answer

Saturday

Registration
7:00 – 8:00 a.m.

8:00 – 9:00 a.m.
Guest Speaker – Neal Rouzier, MD

Alzheimer’s Dementia & The Role of Hormones
● Why Aducanumab (Aduhelm) doesn’t hold a candle to E2 for prevention, reversal of
disease, and clinical improvement of both AD and VD based on the literature.
● An evidenced-based review on how to prevent AD, treat, and reverse AD that no one
knows or understands.
● Why hundreds of studies demonstrating prevention and reversal of dementia with
hormones are ignored in favor of monoclonal antibodies, which are not proven effective
and why they are not effective. Review of the generous, impressive data demonstrating
the improvement in clinical symptoms in outcome studies (i.e – the exciting SPECT
scans).
● How and why Estrogen can increase the incidence of AD. How and why Estradiol (E2)
can decrease the risk and incidence of AD. Review of the only drug that has consistently
improved clinical symptoms in AD patients. E2!

9:00 – 9:15 a.m.
Question and Answer

9:15 – 10:15 a.m.
Guest Speaker – Neal Rouzier, MD
Low Testosterone & Associated CVD, AD, and VD Incidence
● Function of neurosteroids as regulators of neuroinflammation.
● How testosterone and its metabolite, E2, reverse both vascular plaque and neuron beta-
amyloid plaque in both men and women.
● The best type of doctor/specialist to prevent AD in men.
● Why testosterone is the best drug for curing type 2 & type 3 diabetes.
● Deciding what testosterone level is optimal.
● A review of outcome studies and what they reveal: testosterone improves memory,
cognition, and clinical symptoms in patients with AD.
● A review of outcome studies and what they reveal: aducanumab did not improve AD
Deeper question: why are these studies ignored?

10:15 – 10:30
Question and Answer

10:30 – 10:45 – BREAK

10:45 – 11:45 a.m.
Guest Speaker – Neal Rouzier, MD

Other Effective Drugs & AD
● Review of thyroid hormone: only T3 and not T4 results in clinical improvement in
plaque, as well as clinical symptoms, memory, and cognition in AD patients.
● Review of another drug proven efficacious in reversing the microglia dysfunction and
improving phagocytosis by macrophages in patients with AD: melatonin and its role in
the circadian rhythm.

11:45 – Noon
Question and Answer

12:00 – 1:15 p.m. LUNCH

1:15 – 2:15 p.m.
Guest Speakers: Ken Sharlin, MD

21st Century Neuroscience: Translational Medicine
Applying the Principles from the Part 1 lecture provides practitioners with a framework of how
these ideas can be applied in clinical practice today
● Introduce principles of neurology and functional medicine.
● The five pillar system of the brain tune up program.
● How to get started on Monday morning.

2:15 – 2:30 Question and Answer

2:30 – 3:30 pm
Guest Speaker: Keith Nichols, MD and Angie Nichols RN

Case Studies in Patient Documentation and Medical Board Audit

3:30 – 4:00 p.m. BREAK

4:00 – 5:00 p.m.
Guest Speaker: Rick Collins, Esq.
Legal Risk Management for Hormone Replacement Therapy Providers

What do health care providers need to know about prescribing testosterone and other drugs to treat deficiencies or improve patient quality of life in a wellness practice?

 Best and worst marketing practices for testosterone replacement clinics

  • Red flags in prescribing bio-identical testosterone and other androgens
  • The U.S. Supreme Court’s landmark new decision in Ruan v United States and how it may impact controlled substance prescribing
  • What to expect if brought before an “endocrinology trained” professional licensing disciplinary board
  • Medical malpractice and other legal considerations associated with prescribing peptides and other compounds not approved by FDA

5:00 – 5:30 pm
Question and Answer

Sunday

Registration
7:00 – 8:00 a.m.

 

8:00 – 9:00 a.m.
Guest Speaker – Neal Rouzier, MD

Human Growth Hormone (HGH) and AD Prevention: What New Research Shows Us
● Why HGH is the third best drug to prevent/reverse AD.
● A literature review demonstrating reversal of beta-amyloid plaque with HGH.
● The use of IGF-1 and IGF-BP3 in the prediction and treatment of AD.
9:00 – 10:00 a.m.
Guest Speaker – Neal Rouzier, MD
Drugs to Reduce Risk Factors of Type 3 Diabetes
● A review of outcome studies on drugs that reduce VF, body weight, DM, and MS, all risk
factors for type 3 diabetes.
● Ways to reverse IMT and plaque scores.

 

10:00 – 10:30 a.m. BREAK

 

10:30 – 11:30 a.m.
Guest Speaker – Neal Rouzier, MD

Human Growth Hormone -An Update: A Literature review of clinical uses, disease
prevention, and clinical trials
● The legality and cost of prescribing HGH (it’s not illegal but it is expensive!)
● Guidelines for HGH testing and diagnosing deficiency (and why to avoid whenever
possible)
● Prescribing HGH for off-label use (both legal and appropriate) but the importance of
good documentation.
● Medical/Legal review and guidelines such as:
○ DO NOT try to bill or submit to insurance.
○ DO NOT send to an endocrinologist for a work-up.
● Prescribing, dosing, monitoring, adjusting, troubleshooting, and laboratory analysis.
● An evidenced-based review on how to prevent, treat, and reverse CVD, CVD, DM, MS,
osteoporosis, cancer, and any other metabolic-related disease.
● Why Growth Hormone does not cause diabetes; it protects against it.
● An EBM review of when HGH increases BS and when it reduces BS.
● Why Growth Hormone does not cause cancer; it protects against it based on multiple
meta-analyses to be reviewed.
● Understanding the balance between IGF-1 and IGF-BP3.
● HGH does not reverse aging (as some studies falsely allude), but it has shown to protect
against CVD, CVD, and DM by lowering visceral fat and increasing muscle mass, as we
will review.
● Review of the most recent summary paper on HGH.
● Supply and demand, cost and availability.
● Secretagogues and tachyphylaxis.

 

11:30 – 12:30 p.m.
Guest Speaker – Neal Rouzier, MD

Treatment of age-related (non-AD) Cognitive Decline: Improving Memory
● The benefits of E2 in shaping dopamine-dependent cognitive processes.
● Testosterone’s role in neurogenesis and cognition.
● Thyroid hormone and neuro-cognitive functioning.
● DHEA’s role in memory loss.
● Review of the use of HGH for cognitive improvement.

 

12:30 p.m. ADJOURN

Speakers

Location & Travel Details

September 16-18, 2022

Travel Details

Airport

Albuquerque International Sunport (ABQ / KABQ)

Address

Tamaya Resort & Spa – Hyatt Regency
1300 Tuyuna Trail
Santa Ana Pueblo, NM 87004

Accommodations

Room Block Rate $229 per night

Expires 8/18/22

Reserve Room

FAQ

If you’re visiting our webpage or were referred to us, then we most definitely feel this summit is for you! This year’s event promises all new content with a specialized focus on breakthroughs in brain health. Not only by attending will you be able to connect deeply with our 6 speakers, but you’ll also be able to better connect with all your fellow colleagues – virtually or in person. We hope to see you in attendance. You won’t want to miss our 7th annual academic summit!

You should attend the summit any way you can. If you have a choice, it is preferred to come in person. In this way, you will receive deeper support from speakers, as well as be able to better connect with your colleagues. However, if you can only attend virtually, we certainly understand, and your experience will be just as enriching. You’ll  have access to our live Q&A session during the conference, as well as to recordings for 2 weeks post conference. We are also there for support after the summit ends, and able to answer questions as they come up for you.